INTEGRATED BIOPHARMA INC (INBP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 5M 10M 15M Q4 '24: 12.7M Q1 '25: 13.6M Q2 '25: 12.6M Q3 '25: 13.9M Q4 '25: 14.2M Q1 '26: 12.7M Q2 '26: 11.3M Q3 '26: 10.1M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Gross Profit Quarterly

-600K 0 600K 1.2M 1.8M Q4 '24: 1.3M Q1 '25: 1.4M Q2 '25: 1.2M Q3 '25: 1.6M Q4 '25: 1.5M Q1 '26: 1M Q2 '26: 29K Q3 '26: -276K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Income Quarterly

-1.2M -800K -400K 0 400K 800K 1.2M Q4 '24: 402K Q1 '25: 490K Q2 '25: 202K Q3 '25: 739K Q4 '25: 589K Q1 '26: 163K Q2 '26: -914K Q3 '26: -1.1M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Net Income Quarterly

-900K -600K -300K 0 300K 600K 900K Q3 '24: 285K Q4 '24: 268K Q1 '25: 259K Q2 '25: 116K Q3 '25: 611K Q1 '26: 123K Q2 '26: -762K Q3 '26: -837K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26

Cost of Revenue Quarterly

0 5M 10M 15M Q4 '24: 11.5M Q1 '25: 12.2M Q2 '25: 11.4M Q3 '25: 12.4M Q4 '25: 12.7M Q1 '26: 11.7M Q2 '26: 11.3M Q3 '26: 10.4M Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Cash Flow Quarterly

-500K 0 500K 1M 1.5M Q4 '24: -186K Q1 '25: 657K Q2 '25: 201K Q3 '25: 616K Q4 '25: 591K Q1 '26: 1.3M Q2 '26: 617K Q3 '26: 517K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Free Cash Flow Quarterly

-400K 0 400K 800K 1.2M Q4 '24: -332K Q1 '25: 601K Q2 '25: 172K Q3 '25: 500K Q4 '25: 581K Q1 '26: 1.1M Q2 '26: 593K Q3 '26: 517K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '24: 30.1M Q3 '24: 30.7M Q1 '25: 30.6M Q2 '25: 31.3M Q3 '25: 31.5M Q1 '26: 31.4M Q2 '26: 31.1M Q3 '26: 31.1M Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.08 -0.05 -0.03 0.00 0.03 0.05 0.08 Q4 '24: 0.00 Q1 '25: 0.01 Q2 '25: 0.03 Q3 '25: 0.04 Q4 '25: 0.04 Q1 '26: 0.03 Q2 '26: -0.01 Q3 '26: -0.06 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.